Cargando…
c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
Type II testicular germ cell tumors (TGCTs) represent the most frequent malignancy in Caucasian males (20–40 years). Even if diagnosed with disseminated disease, >80% of patients are cured; however, a small percentage of cases progress and result in death. It is commonly accepted that these cance...
Autores principales: | Scheri, Katia Corano, Leonetti, Erica, Laino, Luigi, Gigantino, Vincenzo, Gesualdi, Luisa, Grammatico, Paola, Bizzari, Mariano, Franco, Renato, Oosterhuis, J. Wolter, Stoop, Hans, Looijenga, Leendert H.J., Ricci, Giulia, Catizone, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112764/ https://www.ncbi.nlm.nih.gov/pubmed/30159127 http://dx.doi.org/10.18632/oncotarget.25867 |
Ejemplares similares
-
Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
por: Scheri, Katia Corano, et al.
Publicado: (2018) -
c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells
por: Leonetti, Erica, et al.
Publicado: (2019) -
R-Spondin 1/Dickkopf-1/Beta-Catenin Machinery Is Involved in Testicular Embryonic Angiogenesis
por: Caruso, Maria, et al.
Publicado: (2015) -
HGF Modulates Actin Cytoskeleton Remodeling and Contraction in Testicular Myoid Cells
por: Catizone, Angela, et al.
Publicado: (2015) -
VASA mRNA (DDX4) detection is more specific than immunohistochemistry using poly- or monoclonal antibodies for germ cells in the male urogenital tract
por: Boellaard, Willem P.A., et al.
Publicado: (2017)